Publication: Phototoxic reaction induced by pazopanib
| dc.contributor.author | Siriorn Udompanich | en_US |
| dc.contributor.author | Kumutnart Chanprapaph | en_US |
| dc.contributor.author | Natta Rajatanavin | en_US |
| dc.contributor.other | Faculty of Medicine, Ramathibodi Hospital, Mahidol University | en_US |
| dc.date.accessioned | 2019-08-23T11:45:23Z | |
| dc.date.available | 2019-08-23T11:45:23Z | |
| dc.date.issued | 2018-09-01 | en_US |
| dc.description.abstract | © 2018 The Author(s). Published by S. Karger AG, Basel. Multikinase inhibitors (MKIs) are a novel target therapy that offers promising long-term survival for patients with advanced-stage cancer. However, they cause a wide range of adverse reactions, skin and skin appendage being the most prevalent. Photosensitivity reactions are well-recognized effects from certain MKIs such as sunitinib and vandetanib. However, phototoxic reaction induced by pazopanib has never been reported. We present here the first case of pazopanib-induced phototoxic drug reaction in a patient with renal cell carcinoma. | en_US |
| dc.identifier.citation | Case Reports in Dermatology. Vol.10, No.3 (2018), 251-256 | en_US |
| dc.identifier.doi | 10.1159/000494611 | en_US |
| dc.identifier.issn | 16626567 | en_US |
| dc.identifier.other | 2-s2.0-85057242931 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/46361 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057242931&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Phototoxic reaction induced by pazopanib | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057242931&origin=inward | en_US |